biotech · Advanced Solid Tumors · Tumor, Solid · EIKN
Eikon Therapeutics
Eikon Therapeutics is a biotech organization headquartered in Millbrae, USA. It trades on NYSE under ticker EIKN. Primary therapeutic focus areas include Advanced Solid Tumors, Tumor, Solid, Advanced Melanoma, Advanced s
230 Harriet Tubman Way, Millbrae, CA 94030, US HQ
2019 Founded
404 Employees
Public company Type
EIKN · NYSE Ticker
Company details
- Status
- Public
- HQ
- 230 Harriet Tubman Way, Millbrae, CA 94030, US
- Founded
- 2019
- Employees
- 404
- Programs
- 15
- Drugs
- 13
- Patents
- 4
EIK1001
Phase 3 · small molecule · Advanced Melanoma
EIK1001 for Advanced Melanoma is a Phase 3 program (small_molecule) at Eikon Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code EIK1001-006
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Eikon Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Advanced Melanoma
- Status
- active
- Trials
- 1